The Role of Rehabilitation in Arterial Function Properties of Convalescent COVID-19 Patients

Coronavirus disease (COVID-19) is a respiratory disease, although arterial function involvement has been documented. We assess the impact of a post-acute COVID-19 rehabilitation program on endothelium-dependent vasodilation and arterial wall properties. We enrolled 60 convalescent patients from COVI...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical medicine 2023-03, Vol.12 (6), p.2233
Hauptverfasser: Gounaridi, Maria Ioanna, Vontetsianos, Angelos, Oikonomou, Evangelos, Theofilis, Panagiotis, Chynkiamis, Nikolaos, Lampsas, Stamatios, Anastasiou, Artemis, Papamikroulis, Georgios Angelos, Katsianos, Efstratios, Kalogeras, Konstantinos, Pesiridis, Theodoros, Tsatsaragkou, Aikaterini, Vavuranakis, Manolis, Koulouris, Nikolaos, Siasos, Gerasimos
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Coronavirus disease (COVID-19) is a respiratory disease, although arterial function involvement has been documented. We assess the impact of a post-acute COVID-19 rehabilitation program on endothelium-dependent vasodilation and arterial wall properties. We enrolled 60 convalescent patients from COVID-19 and one-month post-acute disease, who were randomized at a 1:1 ratio in a 3-month cardiopulmonary rehabilitation program (study group) or not (control group). Endothelium-dependent vasodilation was evaluated by flow-mediated dilation (FMD), and arterial wall properties were evaluated by carotid-femoral pulse wave velocity (cf-PWV) and augmentation index (AIx) at 1 month and at 4 months post-acute disease. FMD was significantly improved in both the study (6.2 ± 1.8% vs. 8.6 ± 2.4%, < 0.001) and control groups (5.9 ± 2.2% vs. 6.6 ± 1.8%, = 0.009), but the improvement was significantly higher in the study group (rehabilitation) ( < 0.001). PWV was improved in the study group (8.2 ± 1.3 m/s vs. 6.6 ± 1.0 m/s, < 0.001) but not in the control group (8.9 ± 1.8 m/s vs. 8.8 ± 1.9 m/s, = 0.74). Similarly, AIx was improved in the study group (25.9 ± 9.8% vs. 21.1 ± 9.3%, < 0.001) but not in the control group (27.6 ± 9.2% vs. 26.2 ± 9.8 m/s, = 0.15). Convalescent COVID-19 subjects of the study group (rehabilitation) with increased serum levels of circulating IL-6 had a greater reduction in FMD. Conclusively, a 3-month cardiopulmonary post-acute COVID-19 rehabilitation program improves recovery of endothelium-dependent vasodilation and arteriosclerosis.
ISSN:2077-0383
2077-0383
DOI:10.3390/jcm12062233